NCT00369395 2012-04-27A Study of Volociximab in Metastatic MelanomaAbbottPhase 2 Terminated19 enrolled
NCT00099970 2008-08-05Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With ChemotherapyFacet BiotechPhase 2 Completed40 enrolled